<DOC>
	<DOCNO>NCT01652820</DOCNO>
	<brief_summary>Randomized study 2 arm , without mask patient non small cell lung cancer , histologically cytologically confirm , liable surgery , stage IIIB IIIA , accord TNM classification American Joint Committee cancer . In one arm administer concomitant radiotherapy carboplatin-docetaxel-gemcitabine follow docetaxel , arm administer docetaxel-gemcitabine follow concurrent radiotherapy carboplatin-docetaxel</brief_summary>
	<brief_title>Chemotherapy/Radiotherapy Versus Concomitant Chemotherapy Followed Radiotherapy Stage IIIB Non-small Cell Lung Cancer</brief_title>
	<detailed_description />
	<mesh_term>Lung Neoplasms</mesh_term>
	<mesh_term>Carcinoma , Non-Small-Cell Lung</mesh_term>
	<mesh_term>Gemcitabine</mesh_term>
	<mesh_term>Docetaxel</mesh_term>
	<mesh_term>Carboplatin</mesh_term>
	<criteria>Unresectable stage IIIA B NSCLC patient WHO PS 0 1 Weight loss &lt; 5 % within last 3 month At least one measurable lesion Planning CT scan previous randomization Written inform consent Malignant effusion , supraclavicular node SVCS PTV &gt; 2000 cm3 V20 &gt; 35 % FEV1 DLCO &lt; 30 % 1 liter study entry</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2012</verification_date>
	<keyword>LUNG</keyword>
	<keyword>DOCETAXEL</keyword>
	<keyword>GEMCITABINE</keyword>
	<keyword>CARBOPLATIN</keyword>
	<keyword>RADIOTHERAPY</keyword>
</DOC>